{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T06:15:01Z","timestamp":1783664101336,"version":"3.55.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Disease-related malnutrition can develop in colorectal cancer (CRC) patients, negatively affecting postoperative clinical outcomes. Nutritional status should be assessed using standardised tools and laboratory parameters to identify malnourished patients and introduce personalised, targeted dietary interventions based on epigenetics, immunologically-related aspects, and gut microbiome. The primary aim of this study is to analyse the immunonutritional status of CRC patients in the preoperative period. The secondary aim is to assess the link between albumin-to-globulin ratio (AGR), prognostic nutritional index (PNI), and TNM staging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>This study initially included 21 patients with histopathological confirmation of CRC qualified for surgical resection of the tumour. Immunologically-related nutritional status parameters, i.e., AGR and PNI, were calculated for selected 12 patients. The optimal cut-off value of PNI was determined, allowing patients to be divided into two independent groups: PNI-low and PNI-high. The link between AGR, PNI, and TNM was analysed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>TNM classification of the 12 selected participants revealed that most participants classified as T3 (67%), lymph node metastasis was identified in 50% of patients, and there were no distant metastases. Among selected patients, the analysis of mean values of immunological laboratory tests showed that they were within the normal range, except for lymphocyte levels, which were reduced (22.03 \u00b1 7.31%). The optimal cut-off value was set at 51.74 for PNI; thus, patients were accordingly divided into PNI-low and PNI-high groups (&amp;lt;51.74, 34% of cases; \u226551.74, 66%, respectively). PNI-low was initially associated with more advanced cases (based on T assessment) compared to PNI-high (100% versus 75%; respectively); however, it failed to reach statistical significance (p = 0.515; effect size 0.2889; CI 95%, CI\u00a0=\u00a00.0110\u20137.5681). Therefore, this finding should be interpreted with caution. Lymph node metastasis was found more often in the PNI-high group than in the PNI-low group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Overall concentrations of albumin and total protein were not decreased in CRC patients; however, these parameters allow calculation of AGR and PNI. The link between PNI-low and locally advanced cases of CRC based on T assessment can potentially exist; nevertheless, it should be confirmed with more clinical data. Lymph node metastasis was more often observed in the PNI-high group. This status is also related to higher levels of AGR. A PNI-low value is more related to local than distant pathological processes associated with CRC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1869012","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T05:31:00Z","timestamp":1783661460000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunologically-based nutritional status assessment amongst preoperative colorectal cancer patients \u2013 does it link to TNM stage"],"prefix":"10.3389","volume":"17","author":[{"given":"Karolina","family":"Ka\u017amierczak-Siedlecka","sequence":"first","affiliation":[{"name":"Department of Medical Laboratory Diagnostics \u2013 Fahrenheit Biobank BBMRI.pl, Medical University of Gdansk","place":["Gdansk, Poland"]},{"name":"International Centre for Cancer Vaccine Science, University of Gdansk","place":["Gdansk, Poland"]},{"name":"Neodentica Dentistry Center","place":["Gdansk, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Wi\u015bniewski","sequence":"additional","affiliation":[{"name":"Unit of Surgery with Unit of Oncological Surgery, Specialist Hospital in Koscierzyna","place":["Koscierzyna, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kucharski","sequence":"additional","affiliation":[{"name":"Neodentica Dentistry Center","place":["Gdansk, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Stachowska","sequence":"additional","affiliation":[{"name":"Department of Human Nutrition and Metabolomics, Pomeranian Medical University in Szczecin","place":["Szczecin, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Makarewicz","sequence":"additional","affiliation":[{"name":"Unit of Surgery with Unit of Oncological Surgery, Specialist Hospital in Koscierzyna","place":["Koscierzyna, Poland"]},{"name":"2nd Division of Radiology, Medical University of Gdansk","place":["Gdansk, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.clnesp.2025.06.050","article-title":"Prognostic role of global leadership initiative on malnutrition in colorectal cancer patients: a systematic review and meta-analysis","volume":"69","author":"Zhang","year":"2025","journal-title":"Clin Nutr ESPEN"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1503\/cjs.016820","article-title":"Preoperative malnutrition in patients with colorectal cancer","volume":"64","author":"Gupta","year":"2021","journal-title":"Can J Surg"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(24)00390-X","article-title":"The intestinal barrier: a pivotal role in health, inflammation, and cancer","volume":"10","author":"Neurath","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2025.26.5.1661","article-title":"Malnutrition in colorectal cancer patients: association with the lack of eating motivation and inappropriate diet","volume":"26","author":"Anh","year":"2025","journal-title":"Asian Pac J Cancer Prev"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1103617","article-title":"Roles of macrophages on ulcerative colitis and colitis-associated colorectal cancer","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202009_23059","article-title":"Effects of 4 weeks of Lactobacillus plantarum 299v supplementation on nutritional status, enteral nutrition tolerance, and quality of life in cancer patients receiving home enteral nutrition - a double-blind, randomized, and placebo-controlled trial","volume":"24","author":"Ka\u017amierczak-Siedlecka","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jclinepi.2022.04.026","article-title":"The performance of three nutritional tools varied in colorectal cancer patients: a retrospective analysis","volume":"149","author":"Ruan","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.20250238","article-title":"Nutritional status and prognosis in metastatic colorectal cancer: a cohort study","volume":"71","author":"Kapagan","year":"2025","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2022.2076890","article-title":"Prognostic value of the albumin-to-globulin ratio in patients with colorectal cancer: a meta-analysis","volume":"74","author":"Quan","year":"2022","journal-title":"Nutr Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"17272","DOI":"10.1038\/s41598-023-43391-5","article-title":"Preoperative albumin-to-globulin ratio and prognostic nutritional index predict the prognosis of colorectal cancer: a retrospective study","volume":"13","author":"Li","year":"2023","journal-title":"Sci Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.11452","article-title":"Prognostic impact of preoperative albumin-to-globulin ratio in patients with colon cancer undergoing surgery with curative intent","volume":"37","author":"Fujikawa","year":"2017","journal-title":"Anticancer Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.61830","article-title":"The effectiveness of albumin-to-globulin ratio as a prognostic biomarker in primary gastrointestinal cancer: a systematic review and meta-analysis","volume":"16","author":"Delladio","year":"2024","journal-title":"Cureus"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2018.1479683","article-title":"Prognostic importance of the albumin to globulin ratio in metastatic gastric cancer patients","volume":"35","author":"Bozkaya","year":"2019","journal-title":"Curr Med Res Opin"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1219929","article-title":"Prognostic nutritional index as a prognostic biomarker for gastrointestinal cancer patients treated with immune checkpoint inhibitors","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-333533","article-title":"Early detection of colorectal cancer using aberrant circulating cell-free mitochondrial DNA fragmentomics","volume":"74","author":"Wang","year":"2025","journal-title":"Gut"},{"key":"B16","first-page":"100004","article-title":"Circulating cfDNA promoter methylation: an emerging biomarker for early detection of advanced adenoma and colorectal cancer","volume-title":"Transmed","author":"Shi","year":"2026"},{"key":"B17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12920-024-01893-9","article-title":"Circulating-tumour DNA methylation of HAND1 gene: a promising biomarker in early detection of colorectal cancer","volume":"17","author":"Shavali","year":"2024","journal-title":"BMC Med Genomics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s00520-024-08572-6","article-title":"The prognostic value of immune-nutritional status in metastatic colorectal cancer: prognostic nutritional index (PNI)","volume":"32","author":"Keskinkilic","year":"2024","journal-title":"Support Care Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"11517","DOI":"10.1038\/s41598-025-96592-5","article-title":"Preoperative pan-immuno-inflammatory values and albumin-to-globulin ratio predict the prognosis of stage I-III colorectal cancer","volume":"15","author":"Li","year":"2025","journal-title":"Sci Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2022.01.001","article-title":"Faeces from malnourished colorectal cancer patients accelerate cancer progression","volume":"41","author":"Chao","year":"2022","journal-title":"Clin Nutr"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3233\/CBM-230116","article-title":"The clinical value of a nomogram constructed from CEA, CA199, PT, FIB, tumor differentiation and TNM stage in colorectal cancer","volume":"38","author":"Wang","year":"2023","journal-title":"Cancer biomark"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000045229","article-title":"Causal relationship between albumin, total protein, and colorectal cancer risk: a 2-sample Mendelian randomization study","volume":"104","author":"Chen","year":"2025","journal-title":"Med (Baltimore)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"25647","DOI":"10.1038\/s41598-025-10574-1","article-title":"Linear inverse association between prognostic nutritional index and colorectal cancer risk based on NHANES data","volume":"15","author":"Han","year":"2025","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2530689","article-title":"Prognostic and clinicopathological value of fibrinogen-to-albumin ratio in colorectal cancer: a meta-analysis","volume":"57","author":"Su","year":"2025","journal-title":"Ann Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.JCRT_355_19","article-title":"Prognostic significance of the preoperative C-reactive protein-to-albumin ratio in patients with colorectal cancer","volume":"17","author":"Tamagawa","year":"2021","journal-title":"J Cancer Res Ther"},{"key":"B26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12029-025-01307-8","article-title":"Prognostic value of CRP-Albumin-Lymphocyte (CALLY) index in colorectal cancer survival: a multicenter retrospective cohort study","volume":"56","author":"Bahardoust","year":"2025","journal-title":"J Gastrointest Cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"14428","DOI":"10.1038\/s41598-024-65457-8","article-title":"Predicting prognosis in colorectal cancer patients with curative resection using albumin, lymphocyte count and RAS mutations","volume":"14","author":"Miyata","year":"2024","journal-title":"Sci Rep"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-087426","article-title":"Development and validation of a risk prediction model related to inflammatory and nutritional indexes for postoperative pulmonary infection after radical colorectal cancer surgery","volume":"15","author":"Han","year":"2025","journal-title":"BMJ Open"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1186\/s12885-025-15165-x","article-title":"The prognostic role of inflammation-based hematologic markers in stage I-III colorectal cancer: a retrospective analysis","volume":"25","author":"Li","year":"2025","journal-title":"BMC Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2017.1285038","article-title":"Preoperative prognostic nutritional index correlates with severe complications and poor survival in patients with colorectal cancer undergoing curative laparoscopic surgery: a retrospective study in a single Chinese institution","volume":"69","author":"Cao","year":"2017","journal-title":"Nutr Cancer"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1536807","article-title":"Predictive value of preoperative inflammatory response markers on short-term postoperative complications following colorectal surgery: a secondary analysis of a randomized clinical trial","volume":"12","author":"Bu","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/nu15122772","article-title":"Comparative effects of different nutritional supplements on inflammation, nutritional status, and clinical outcomes in colorectal cancer patients: a systematic review and network meta-analysis","volume":"15","author":"Ye","year":"2023","journal-title":"Nutrients"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1606187","article-title":"The impact of enteral immunonutrition on gut microbiota in colorectal cancer and gastric cancer patients in the preoperative period\u2014preliminary results of randomized clinical trial","volume":"16","author":"Ka\u017amierczak-Siedlecka","year":"2025","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S243172","article-title":"Impact of nutritional indices on the survival outcomes of patients with colorectal cancer","volume":"12","author":"Hu","year":"2020","journal-title":"Cancer Manag Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1869012\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T05:31:01Z","timestamp":1783661461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1869012\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":34,"alternative-id":["10.3389\/fimmu.2026.1869012"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1869012","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"article-number":"1869012"}}